References:
1. Mohseni Afshar Z, Babazadeh A, Hasanpour A, Barary M, Sayad B,
Janbakhsh A, et al. Dermatological manifestations associated with
COVID‐19: A comprehensive review of the current knowledge. Journal of
medical virology. 2021;93(10):5756-67.
2. Hatami P, Nicknam Asl H, Aryanian Z. Cutaneous Manifestations of
COVID-19 in Children: Practical Points for Clinicians. J Skin Stem
Cell.8(4):e122260. doi: 10.5812/jssc.122260.
3. Hatami P, Aryanian Z., Nicknam Asl H, Goodarzi A. Mucocutaneous
adverse effects following COVID-19 vaccination: A comprehensive review
of the literature with a presentation of some cases from Iran. Iranian
Journal of Dermatology.2021 Dec. Doi: 10.22034/IJD.2021.311094.1451
4. Mohaghegh F, Hatami P, Aryanian Z. A case of atypical disseminated
herpes zoster in a patient with COVID-19; a diagnostic challenge in
COVID era. J Clinical Case Reports. 2022.
Doi: 10.1002/ccr3.5342
5. Miladi R, Janbakhsh A, Babazadeh A, Aryanian Z, Ebrahimpour S, Barary
M, et al. Pustular psoriasis flare‐up in a patient with COVID‐19.
Journal of Cosmetic Dermatology. 2021;20(11):3364-8.
6. Babazadeh A, Miladi R, Barary M, Shirvani M, Ebrahimpour S, Afshar
ZM. COVID-19 vaccine-related new-onset lichen planus. Authorea
Preprints. 2021.
7. Pigliacelli F, Pacifico A, Mariano M, D’Arino A, Cristaudo A,
Iacovelli P. Morphea induced by SARS-CoV-2 infection: A case report.
International journal of dermatology. 2021.
8. Lotfi Z, Haghighi A, Akbarzadehpasha A, Mozafarpoor S, Goodarzi A.
Pansclerotic morphea following COVID-19: A case report and review of
literature on rheumatologic and non-rheumatologic dermatologic
immune-mediated disorders induced by SARS-CoV-2. Frontiers in medicine.
2021;8.
9. Hatami P, Balighi K, Nicknam Asl H, Aryanian Z. Serious health threat
of mucormycosis during the ongoing COVID-19 pandemic: what
dermatologists need to know in this regards.Int. J. Derm.2022 Jan
10. Severino P. Morphea (Localized Scleroderma) in a COVID-19 patient: A
Case Report. J Clin Immunol Microbiol. 2021;2(1):1-4.
11. Hatami P, Balighi K, Nicknam Asl H, Aryanian Z. COVID vaccination in
patients under treatment with rituximab: A presentation of two cases
from Iran and a review of the current knowledge with a specific focus on
pemphigus. Dermatol Ther. 2021 Nov 23:e15216. doi: 10.1111/dth.15216.
Epub ahead of print. PMID: 34811862.
12. Bogdanov G, Bogdanov I, Kazandjieva J, Tsankov N. Cutaneous adverse
effects of the available COVID-19 vaccines. Clinics in Dermatology.
2021.
13. Burlando M, Herzum A, Micalizzi C, Cozzani E, Parodi A. Cutaneous
reactions to COVID‐19 vaccine at the dermatology primary care. Immunity,
inflammation and disease. 2021.
14. Fett N, Werth VP. Update on morphea: part I. Epidemiology, clinical
presentation, and pathogenesis. Journal of the American Academy of
Dermatology. 2011;64(2):217-28.
15. Coelho‐Macias V, Mendes‐Bastos P, Assis‐Pacheco F, Cardoso J.
Imatinib: a novel treatment approach for generalized morphea.
International journal of dermatology. 2014;53(10):1299-302.
16. Khatri S, Torok KS, Mirizio E, Liu C, Astakhova K. Autoantibodies in
morphea: an update. Frontiers in immunology. 2019;10:1487.
17. Farhangdoost F. The role of infection in morphea disease. Reviews in
Clinical Medicine. 2015;2(4):187-9.
18. Șandru F, Popa A, Petca A, Miulescu RG, Constantin MM, Petca RC, et
al. Etiologic role of Borrelia burgdorferi in morphea: A case report.
Experimental and Therapeutic Medicine. 2020;20(3):2373-6.
19. Soylu S, Gül Ü, Gönül M, Kilic A, Çakmak SK, Demiriz M. An Uncommon
Presentation of the Co-Existence of Morphea and Vitiligo in a Patient
with Chronic Hepatitis B Virus Infection. American journal of clinical
dermatology. 2009;10(5):336-8.
20. Solovăstru L, Amălinei C. Morphea associated with toxoplasmosis.
Revista medico-chirurgicala a Societatii de Medici si Naturalisti din
Iasi. 2003;107(3):646-9.
21. Bashir AH, EL-Hassan LA, Muddathir AK, Mithani A, Sidahmed AB,
Elhassan GO, et al. Case Report: Morphea Profunda Associated with
Helicobacter pylori Infection in Sudanese Patient. American Journal of
Dermatology and Venereology. 2015;4(2):13-4.
22. Telakis E, Nikolaou A. Localized scleroderma (morphea) in a patient
with chronic hepatitis C. European journal of gastroenterology &
hepatology. 2009;21(4):396.
23. de Oliveira FL, de Barros Silveira LKC, Rambaldi MLC, Barbosa FC.
Localized scleroderma associated with chronic hepatitis C. Case reports
in dermatological medicine. 2012;2012.
24. Nahidi Y, Tayyebi Meibodi N, Meshkat Z, Salehi M, Farhangdoost F.
Evaluation of the association between Morphea and Cytomegalovirus in a
cross sectional study. medical journal of mashhad university of medical
sciences. 2017;60(3):494-502.
25. Kowalczyk MJ, Dańczak-Pazdrowska A, Szramka-Pawlak B, Żaba R,
Osmola-Mańkowska A, Silny W. Human endogenous retroviruses and chosen
disease parameters in morphea. Advances in Dermatology and
Allergology/Postȩpy Dermatologii i Alergologii. 2017;34(1):47.
26. Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc
D, et al. Covid-19 and autoimmunity. Autoimmunity reviews.
2020;19(8):102597.
27. Nobari NN, Montazer F, Seirafianpour F, Goodarzi A. Histopathologic
changes and cellular events of organs systems in COVID-19. Journal of
Cellular and Molecular Anesthesia. 2021;6(1):81-8.
28. Viladomiu E, Valls A, Zabaleta B, Moreno A, Pérez N. Deep morphea in
a child after pneumococcal vaccination. Indian journal of dermatology,
venereology and leprology. 2014;80(3):259.
29. Torrelo A, Suárez J, Colmenero I, Azorín D, Perera A, Zambrano A.
Deep morphea after vaccination in two young children. Pediatric
dermatology. 2006;23(5):484-7.
30. Bukhari I, Al Breiki S. Post vaccination localized morphea. Journal
of Chinese Clinical Medicine. 2009;4(10).
31. Dursun R. Morphea DevelopIng After HepatItIs B VaccInatIon. Selcuk
Medical Journal. 2005;21(3):83-7.
32. Matsumoto M, Yamamoto T. Pediatric generalized morphea that
developed at a BCG vaccination site. Actas dermo-sifiliograficas.
2014;106(2):150-2.
33. Kim J, Chung KB, Lee YI, Kim J, Lee JH. Clinical characteristics and
histopathologic changes of morphea: A single-center, retrospective study
of 137 patients. Journal of the American Academy of Dermatology.
2021;85(1):105-13.
34. Leitenberger JJ, Cayce RL, Haley RW, Adams-Huet B, Bergstresser PR,
Jacobe HT. Distinct autoimmune syndromes in morphea: a review of 245
adult and pediatric cases. Archives of dermatology. 2009;145(5):545-50.
35. Desmond BL, Blattner CM, Young III J. Generalized morphea as the
first sign of breast carcinoma: a case report. Dermatology online
journal. 2016;22(2).
36. Pappova T, Pec J, Kozarova A, Adamicova K. Cutaneous Paraneoplastic
Manifestation (Morphea, Lichen Sclerosus)-Two Case Reports. Acta Medica
Martiniana. 2017;17(1):28.
37. Grewal I, Khan O, Davis W. Squamous cell carcinoma and eosinophilia
in a long-term course of pansclerotic morphea. Case Reports.
2014;2014:bcr2014205737.
38. Nashel J, Steen V. Scleroderma mimics. Current rheumatology reports.
2012;14(1):39-46.
39. Afshar ZM, Babazadeh A, Javanian M, Barary M, Rekha VVK, Ebrahimpour
S. A comprehensive review of COVID-19 treatment. Acta facultatis medicae
Naissensis. 2021;38(2):105-15.
40. Martinez-Lopez A, Cuenca-Barrales C, Montero-Vilchez T, Molina-Leyva
A, Arias-Santiago S. Review of adverse cutaneous reactions of
pharmacologic interventions for coronavirus disease 2019 (COVID-19): a
guide for the dermatologist. Journal of the American Academy of
Dermatology. 2020.
41. Schwartz RA, Sharma A, Lotti T, Szepietowski JC, Sandhu S, Goldust
M. Systemic Medications of Dermatological Importance in COVID-19. J
Drugs Dermatol. 2020;19:217-20.
42. Lee EY, Glassman SJ. Deep morphea induced by interferon-β1b
injection. JAAD case reports. 2016;2(3):236.
43. Fett N, Werth VP. Update on morphea: part II. Outcome measures and
treatment. Journal of the American Academy of Dermatology.
2011;64(2):231-42.
44. Aryanian Z, Shojaee N, Goodarzi A, Shirzadian A, Hatami P. Influence
of Narrow-Band Ultra Violet B Phototherapy on Homocysteine Status: A
Prospective Study of Patients with Different Cutaneous Disorders.
Photobiomodulation, Photomedicine, and Laser Surgery. 2021;39(9):607-11.